Faculty

Elias J. Anaissie, MD
University of Arkansas for Medical Sciences, Little Rock, Arkansas

Nelson Chao, MD
Duke University Medical Center, Durham, North Carolina

Dimitrios P. Kontoyiannis, MD
MD Anderson Cancer Center, Houston, Texas

James S. Lewis, PharmD
University of Texas Health Science Center, San Antonio, Texas

Kieren Marr, MD
Fred Hutchinson Cancer Research Center, Seattle, Washington

Luis Ostrosky-Zeichner, MD
University of Texas Health Science Center, Houston, Texas

Michael G. Rinaldi, PhD
University of Texas Health Science Center at San Antonio
San Antonio, Texas

Kenneth V. Rolston, MD
MD Anderson Cancer Center, Houston, Texas

Kent Sepkowitz, MD
Memorial Sloan-Kettering Cancer Center, New York, New York

William J. Steinbach, MD
Duke University, Durham, North Carolina

John R. Wingard,MD
University of Florida, Gainesville, Florida

Drew J. Winston, MD
UCLA Medical Center, Los Angeles, California

Dr. Chao is Professor of Medicine and Immunology and the Chief of the Division of Cellular Therapy/BMT at Duke University. He received his undergraduate degree from Harvard University, MD from Yale University and his post-graduate training at Stanford University. He then joined the faculty at Stanford University. He was the Associate Director of Stem Cell Transplantation at Stanford University prior to moving to Duke University in 1996. He obtained his MBA from the Fuqua School of Business at Duke University in 2000. He is the author of over 100 peer-reviewed papers, 25 book chapters and one book. He is also a co-founder of Stemco Biomedical, a start up biotechnology company in Research Triangle Park.

back to top

Dr. Elizabeth Dodds Ashley is Associate in Research, Division of Infectious Diseases, Department of Medicine, Duke University Medical Center and Clinical Assistant Professor, Department of Pharmacy Practice, Campbell University School of Pharmacy. Dr. Dodds Ashley has been active in the field of infectious diseases pharmacotherapy for the past 5 years. Her teaching, research and patient care activities focus on infectious diseases in the transplant population. Recent areas of research include, pharmacokinetics of antifungal agents, preventative strategies for invasive fungal infections in solid organ and bone marrow transplant recipients, and prophylactic strategies for cytomegalovirus (CMV) disease. She is a member of the Duke University Antimicrobial Trials Unit and is an investigator on several industry-sponsored as well as investigator-initiated clinical trials. As co-director of the Center of Excellence for Rational Use of Antibiotics, she is actively involved in promoting appropriate antimicrobial prescribing and designing continuing education programs at the institutional and state-wide level. She has been involved in the local chapter of ACCP for the past 6 years, serving as President in 2003.

back to top

Steven Gabardi received his Pharm.D. in May of 1999 from Butler University, Indianapolis, IN. Dr. Gabardi did his post-doctoral training at Tufts- New England Medical Center in Boston, MA, completing his residency in pharmacy practice in 2000. After completion of his residency program, Dr. Gabardi took a position as a Renal Transplant Clinical Specialist at Brigham and Women's Hospital, with an appointment as an Assistant Clinical Professor at Northeastern University's Bouvé College of Health Sciences, both in Boston, MA. In December of 2003, Dr. Gabardi earned his certification as a Board Certified Pharmacotherapy Specialist, one of only approximately two thousand pharmacists who have earned this certification worldwide. Dr. Gabardi has expertise in the areas of solid-organ transplantation with a focus on renal transplant, with several publications in this clinical area. His other areas of interest include infectious disease and nephrology. He is currently carrying out clinical research in the areas of solid-organ transplantation and infectious disease.

back to top

Paul O. Gubbins, PharmD is currently an Associate Professor and Chair of the Department of Pharmacy Practice. Dr. Gubbins received his Pharm.D from the University of Illinois at Chicago, and did a two year General Residency at the University of Kentucky. Upon completing his residency he returned to his alma mater to complete a research fellowship in Infectious Disease Pharmacology. Dr. Gubbins is a member of the UAMS Infectious Disease Consult Service at University Hospital. He has published many articles concerning the pharmacokinetics and use of antifungal agents.

back to top

Mary F. Hebert, PharmD is an Associate Professor in the Department of Pharmacy at the University of Washington. She earned her Pharm.D. degree from the University of California, San Francisco in 1987. This was followed by a Clinical Pharmacy Residency and a two-year research fellowship at UCSF. Dr. Hebert has been recognized as a Fellow by the American College of Clinical Pharmacy. She is involved in the teaching and mentoring of pharmacy students, residents and fellows. She has been conducting clinical trials for 15 years resulting in 40 publications. In addition, she has been an invited lecturer at national and international meetings. She has served as a consultant as well as conducted clinical research with several pharmaceutical companies and has ongoing research projects with the FDA and NIH. Her research interests have been in the pharmacokinetics and pharmacodynamics of agents used in solid organ transplantation.

back to top

Dr. Dimitrios P. Kontoyiannis is Associate Professor of Medicine and Director of Clinical Mycology at the University of Texas MD Anderson Cancer Center and Adjunct Associate Professor, Division of Pharmacology, at the University of Houston. Dr. Kontoyiannis attended National and Kapodistrian University of Athens Medical School. He completed a residency program at Baylor College of Medicine where he was a chief resisent. He did his fellowship in Infectious Disease at Massachusetts General Hospital, Harvard Medical School. He did a eresearch fellowship in yeast genetics at the Whitehead Institute at MIT in Boston. Dr. Kontoyiannis is board certified in Infectious Disease and Internal Medicine.

Dr. Kontoyiannis's research interests focus on clinical mycology, antifungal resistance and fungal pathogenesis.He has published over a 100 articles on mycology in many scientific journals, including The Lancet and New England Journal of Medicine. In addition, he serves on the editorial board of Transplant Infectious Disease. Dr. Kontoyiannis has conducted clinical research in clinical mycology and infections in immunocompromised patients, and is a member of the Infectious Disease Society of America.

back to top

Kieren Marr is currently an Assistant Member at the Fred Hutchinson Cancer Research Center and an Assistant Professor of Medicine at the University of Washington in Seattle, WA. Her research is focused on Aspergillus pathogenesis, and prevention and early diagnosis of invasive mould infections in immunocompromised patients. She was trained in microbiology at California State University and subsequently investigated toxoplasmosis and EBV-associated lymphoma in laboratories at Stanford and the National Institutes of Health. She received her MD degree at Hahnemann University, and completed her internship and residency in Internal Medicine at Duke University, where she also served as Assistant Chief Resident. She performed infectious diseases training at the University of Washington. Dr. Marr has received a number of honors during her training, including a Cancer Federation Award, the American Medical Women’s Association Citation, Membership to Alpha Omega Alpha, and the National Federation of Infectious Diseases Medical Mycology Fellowship. She currently serves on the program committee of the Infectious Diseases Society of America, the council of the Immunocompromised Host Society, and multiple editorial boards.

back to top

Dr. Ostrosky-Zeichner obtained his medical degree from Universidad Nacional Autonoma de Mexico. He did his internal medicine residency at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, and his infectious diseases fellowship at the University of Texas- Houston Medical School and M.D. Anderson Cancer Center combined fellowship program. He has advanced training and experience in medical mycology and hospital epidemiology.

He is currently an assistant professor of medicine and epidemiology at the Division of Infectious Diseases of the University of Texas- Houston Medical School, where he also serves as the associate fellowship program director and medical director for epidemiology for Memorial Hermann Hospital. He is a fellow of the American College of Physicians and he actively pursues translational and clinical research in medical mycology and hospital epidemiology, having over 90 publications in both fields. His areas of expertise include: antifungal susceptibility testing, fungal serologies, pharmacokinetics/pharmacodynamics of antifungals, in vivo models of human mycoses, immunology, and clinical trials in prophylaxis and treatment of fungal infections, as well as hospital epidemiology and infection control.

back to top

Dr. Rinaldi received his graduate training at the University of California, Davis, where he received the PhD Degree in Microbiology in 1980 in the Section of Infectious and Im-munologic Diseases. Dr. Rinaldi has concentrated on the laboratory evaluation of anti-fungal agents and has been involved for many years in work surrounding standardiza-tion of in vitro antifungal susceptibility testing, most recently under the auspices of the National Committee for Clinical Laboratory Standards Subcommittee on Antifungal Sus-ceptibility Testing.

Over his career, Dr. Rinaldi has published over 260 peer-reviewed papers, 25 book chapters and one book. He is Co-Editor of Current Topics in Medical Mycology and on the editorial boards of 5 journals. Dr. Rinaldi is Co-Chairman/Developer of a 12-year running U.S. meeting-series, "Focus on Fungal Infections". Dr. Rinaldi is perhaps most noted for his oral presentations concerning opportunistic fungal infections, has been in-vited to speak around the globe and is often termed "the international missionary for medical mycology".

back to top

Dr. Wingard is Professor of Medicine and Pediatrics, Director of the Bone Marrow Transplant Program, and Associate Director for Clinical and Translational Research of the University of Florida Shands Cancer Center in the College of Medicine in Gainesville, FL. Dr. Wingard received his BA degree from Yale University and his MD degree at Johns Hopkins University School of Medicine. He served his residency at the University of Tennessee, Center for Health Sciences, and then completed his fellowship in Medical Oncology at Johns Hopkins, where he remained on the faculty for 14 years until he accepted a position at Emory University in 1991. At Emory, he was the Director of the Bone Marrow Transplant Program for 3 years before accepting his current position at the University of Florida. Dr. Wingard is the primary or co-author of 216 research articles, 273 abstracts, 33 book chapters, and the editor of 2 books. He is Co-Chair of the Late Effects of the International Bone Marrow Transplant Registry, Past-President of the American Society for Blood and Marrow Transplantation, is an Associate Editor of Biology of Blood and Marrow Transplantation, serves on the editorial boards of Transplant Infectious Disease, Stem Cells, and Clinical Advances in Hematology and Oncology, and is Editor of Blood and Marrow Transplant Reviews.

back to top

Dr. Steinbach is an Assistant Professor of Pediatrics (Pediatric Infectious Diseases), Molecular Genetics, and Microbiology at Duke University Medical Center. He is also the director of the Duke University Aspergillus Laboratory and a collaborator with the Duke Clinical Research Institute. He has just returned from a sabbatical in the Unité des Aspergillus at the Institut Pasteur in Paris. His research interests include both clinical investigation and basic science advances. Dr. Steinbach’s NIH-funded research centers on molecular mechanisms of Aspergillus fumigatus pathogenesis, including in vitro and animal model testing of mutant strains and antifungals. His specific clinical interest is in the treatment of invasive aspergillosis and pediatric fungal infections. Most recently, Dr. Steinbach is the Co-Chair of an international conference designed to highlight the latest thoughts, contributions, and future goals in Aspergillus research, scheduled for September 9-11th, 2004 in San Francisco (www.advancesagainstaspergillosis.org).

back to top

Dr. Kent Sepkowitz received his B.A. in English then his M.D. from the University of Oklahoma in 1980 and completed his residency and chief residency in Internal Medicine at Roosevelt Hospital in New York City. After a fellowship in Infectious Diseases at Memorial Sloan-Kettering Cancer Center (MSKCC), he joined the faculty, where he has remained. He currently is a Member, Memorial Hospital and a Professor of Medicine, Weill Medical College of Cornell University. He is Director of Infection Control at MSKCC. He is the author of over 150 articles, chapters, and reviews on issues relating to the immunocompromised hosts, bioterrorism, and other topics. He is the recipient of an NIH Mid-Career Development Award and heads CDC-funded Prevention Epicenter activities at MSKCC.

back to top

Local Chairs

Dr. Joe Files is the director of the Bone Marrow Transplant Program at the University of Mississippi Medical Center where he is a Professor of Medicine and Director of the Hematology Division, and has been practicing there for 25 years. He is also the Associate Chairman for the Department of Medicine and is the Director of the UMC Cancer Institute that opened in January, 2004. He is also active in the American College of Physicians where he is beginning his final year of a four-year appointment as Governor of the Mississippi Chapter.

back to top